SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16929122
Source:
http://linkedlifedata.com/resource/pubmed/id/16929122
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0010583
,
umls-concept:C0016360
,
umls-concept:C0025677
,
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0439658
,
umls-concept:C0439858
,
umls-concept:C1556094
pubmed:issue
3
pubmed:dateCreated
2006-8-24
pubmed:abstractText
Few reports have addressed the feasibility and safety of classic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) therapy in Japanese female breast cancer patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100888201
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
pubmed:status
MEDLINE
pubmed:issn
1340-6868
pubmed:author
pubmed-author:IijimaKohtaroK
,
pubmed-author:ItoYoshinoriY
,
pubmed-author:IwaseTakujiT
,
pubmed-author:KasumiFujioF
,
pubmed-author:MakitaMasujiroM
,
pubmed-author:MiyagiYumiY
,
pubmed-author:NishimuraSeiichiroS
,
pubmed-author:TadaKeiichiroK
,
pubmed-author:TakahashiKaoruK
,
pubmed-author:TakahashiShunjiS
,
pubmed-author:YoshimotoMasatakaM
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-83
pubmed:meshHeading
pubmed-meshheading:16929122-Adult
,
pubmed-meshheading:16929122-Aged
,
pubmed-meshheading:16929122-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:16929122-Breast Neoplasms
,
pubmed-meshheading:16929122-Cyclophosphamide
,
pubmed-meshheading:16929122-Feasibility Studies
,
pubmed-meshheading:16929122-Female
,
pubmed-meshheading:16929122-Fluorouracil
,
pubmed-meshheading:16929122-Humans
,
pubmed-meshheading:16929122-Japan
,
pubmed-meshheading:16929122-Maximum Tolerated Dose
,
pubmed-meshheading:16929122-Methotrexate
,
pubmed-meshheading:16929122-Middle Aged
pubmed:year
2006
pubmed:articleTitle
Tolerability and safety of classic cyclophosphamide, methotrexate, and fluorouracil treatment in Japanese patients with early breast cancer.
pubmed:affiliation
Department of Breast Oncology, Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. ktada@jfcr.or.jp
pubmed:publicationType
Journal Article